In situ arterial allografting for aortoiliac graft infection: A 6-year experience

Vascular

Volumn 4, Issue 4, 1996, Pages 495-499

  Koskas, F ^a   Plissonnier, D ^a   Bahnini, A ^a   Ruotolo, C ^a   Kieffer, E ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

arterial allograft; arterial infection; graft infection

Indexed keywords

ADULT; AGED; ALLOGRAFT; ARTERY GRAFT; ARTICLE; FEMALE; GRAFT INFECTION; GRAFT PATENCY; HUMAN; ILIAC ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0030207695     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099600400416     Document Type: Article

References (22)

1. Goldstone J, Moore WS. Infections in vascular prostheses: clinical manifestations and surgical management. Am J Surg 1974; 128: 225–233.
2. Lorentzen JE, Nielsen OM, Arendrup H, et al Vascular graft infection: an analysis of 62 graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 1985; 98: 81–86.
3. Curl GR, Rocotta JJ. Total prosthetic graft excision and extra-anatomic bypass. In: Calligaro KD, Veith FJ, eds. Management of Infected Arterial Grafts. St Louis: Quality Medical Publishing 1994: 82–94.
4. Reilly LM. Autogenous conduits in the management of prosthetic aortic graft infection. In: Calligaro KD, Veith FJ, eds. Management of Infected Arterial Grafts. St Louis: Quality Medical Publishing, 1994: 95–105.
5. Moore WS, Swanson RJ, Campagna G, Bean B. The use of fresh tissue arterial substitutes in infected fields. J Surg Res 1975; 18: 229–233.
6. Clagett GP. A new option for treatment of infected aortic prostheses: the NAIS operation. In: Calligaro KD, Veith FJ, eds. Management of Infected Arterial Grafts. St Louis: Quality Medical Publishing, 1994: 124–141.
7. Snyder SA, Wheeler JR, Gregory TR, et al Freshly harvested cadaveric venous homografts as arterial conduits in infected fields. Surgery 1987; 101: 283–291.
8. Goéau-Brissonnière O, Leport C, Bacourt F, et al Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg 1991; 5: 408–412.
9. Chervu A, Moore WS, Gelabert HA, et al Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg 1991; 14: 521–525.
10. Colburn MD, Moore WS, Chvapil M, et al Use of an antibiotic bonded graft for in-situ reconstruction following prosthetic graft infections. J Vasc Surg 1992; 16: 651–660.
11. Torsello G, Sandmann W, Ghert A, Jungblut R. In situ replacement of infected vascular prosthesis with rifampinsoaked vascular grafts: early results. J Vasc Surg 1993; 17 768–773.
12. Carrel A. Ultimate result of aortic transplantation. J Exp Med 1912; 15: 389–398.
13. Oudot J, Beaconsfield P. Thrombosis of the aortic bifurcation treated by resection and homograft replacement. Arch Surg 1953; 66: 365–374.
14. Dubost C, Allary M, Oeconomos N. Resection of an aneurysm of the abdominal aorta: re-establishment of the continuity by a preserved human arterial graft, with results after five months Arch Surg 1952; 64: 405–408.
15. Szilagyi DE, Rodriguez FJ, Smith RF, Elliott JP. Late fate of arterial allografts: observations 6 to 15 years after implantation. Arch Surg 1970; 101: 721–733.
16. Zwischenberger JB, Shalaby TZ, Conti VR. Viable cryopreserved aortic homograft for aortic valve endocarditis and annular abscesses. Arm Thorac Surg 1989; 48: 365–370.
17. Bahnini A, Ruotolo C, Koskas F, Kieffer E. In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months' follow-up. J Vasc Surg 1991; 14: 98–102.
18. Kieffer F., Bahnini A, Koskas F, et al In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg 1993; 17: 349–356.
19. Bacourt F, Koskas F and Association Universitaire de Recherche en Chirurgie. Axillo-bifemoral bypass and aortic exclusion for vascular septic lesions: a multicenter retrospective study. Ann Vasc Surg 1992; 6: 119–126.
20. Bandyk DF, Bergamini TM, Kinney FV, et al. In situ replacement of vascular prostheses infected by bacterial biofilms. J Vasc Sure 1991; 13: 575–583.
21. Schmitz-Rixen T, Megerman J, Colvin RB, et al Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988; 7: 82–92.
22. Plissonnier D, Levy BI, Salzemann JL, et al Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats. Arteriosclerosis and Thrombosis 1991; 11: 1690–1699.